T. Rowe Price Investment Management
HZNP

T. Rowe Price Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

T. Rowe Price Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,029,711
Closed -$331M – 596
2023
Q1 		$331M Sell
3,029,711
-1,020,548
-25% -$111M 0.24% 116
2022
Q4 		$461M Buy
+4,050,259
New +$461M 0.35% 81